Heat-killed probiotic bacteria differentially regulate colonic epithelial cell production of human β-defensin-2: Dependence on inflammatory cytokines

Beneficial Microbes

Volumn 5, Issue 4, 2014, Pages 483-495

  Habil, N ^a,b   Abate, W ^a   Beal, J ^a   Foey, A D ^a  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b FOUNDATION OF TECHNICAL EDUCATION   (Iraq)

Author keywords

Epithelial cells; Inflammation; Probiotics; defensin 2

Indexed keywords

BETA DEFENSIN 2; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; BETA DEFENSIN; DEFB4A PROTEIN, HUMAN; IMMUNOLOGIC FACTOR;

ARTICLE; BACTERIAL STRAIN; CACO 2 CELL LINE; COLON MUCOSA; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HEAT TREATMENT; HUMAN; HUMAN CELL; IMMUNOMODULATION; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; BIOSYNTHESIS; GENE EXPRESSION PROFILING; HEAT; IMMUNOLOGY; METABOLISM; MICROBIAL VIABILITY; RADIATION RESPONSE;

BETA-DEFENSINS; CACO-2 CELLS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HOT TEMPERATURE; HUMANS; IMMUNOLOGIC FACTORS; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; MICROBIAL VIABILITY; PROBIOTICS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84907027851     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2013.0061     Document Type: Article

References (42)

1. Aldhous, M.C., Noble, C.L. and Satsangi, J., 2009. Dysregulation of human β-defensin-2 protein in inflammatory bowel disease. PLoS ONE 4: e6285.
2. Biragyn, A., Ruffini, P.A., Leifer, C.A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A.K., Farber, J.M., Segal, D.M., Oppenheim, J.J. and Kwak, L.W., 2002. Toll-like receptor 4-dependent activation of dendritic cells by β-defensin 2. Science 298: 1025-1029.
3. Chaly, Y., Paleolog. E., Kolesnikova, T., Tikhonov, I., Petratchenko, E. and Voitenok, N., 2000. Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. European Cytokine Network 11: 257-266.
4. Chertov, O., Michiel, D.F., Xu, L., Wang, J.M., Tani, K., Murphy, W.J., Longo, D.L., Taub, D.D. and Oppenheim, J.J., 1996. Identification of defensin-1, defensin-2 and CAP37/azurocidin as T cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. Journal of Biological Chemistry 271: 2935-2940.
5. Cope, A.P., 1998. Regulation of autoimmunity by proinflammatory cytokines. Current Opinions in Immunology 10: 669-676.
6. Cope, A.P., Liblau, R.S., Yang, X-D., Congia, M., Laudanna, C., Schreiber, R.D., Probert, L., Kollias, G. and McDevitt, H.O., 1997. Chronic tumour necrosis factor alters T cell responses by attenuating T cell receptor signalling. Journal of Experimental Medicine 185: 1573-1584.
7. Cope, A.P., Londei, M., Chu, N.R., Cohen, S.B.A., Elliott, M.J., Brennan, F.M., Maini, R.N. and Feldmann, M., 1994. Chronic exposure to tumour necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. Journal of Clinical Investigation 94: 749-760.
8. Fleming, S.D. and Campbell, P.A., 1996. Macrophages have cell surface IL-10 that regulates macrophage bacteriocidal activity. Journal of Immunology 156: 1143-1150.
9. Foey, A.D., 2012. Mucosal macrophages: phenotype and functionality in homeostasis and pathology. In: Takahashi, R. and Kai, H. (eds.) Handbook of macrophages: life cycle, functions and diseases. Nova Science Publishers, Inc., New York, NY, USA, pp. 121-146.
10. Ganz, T., 2003. Defensins: antimicrobial peptides of innate immunity. Nature Reviews in Immunology 3: 710-720.
11. Garcia, J.R., Jaumann, F., Shulz, S., Krause, A., Rodriguez-Jimenez, J., Forssmann, U., Adermann, K., Kluver, E., Vogelmeier, C., Becker, D., Hedrich, R., Forssmann, W.G. and Bals, R., 2001. Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell and Tissue Research 306: 257-264.
12. 17cells on inflamed endothelium in vitro under flow conditions. Journal of Immunology 186: 1411-1420.
13. Habil, N., Al-Murrani, W., Beal, J. and Foey, A.D., 2011. Probiotic bacterial strains differentially modulate macrophage cytokines in a strain-dependent and cell subset-specific manner. Beneficial Microbes 2: 283-293.
14. Habil, N., Beal, J. and Foey, A.D., 2012. Lactobacillus casei strain Shirota selectively modulates macrophage subset cytokine production. International Journal of Probiotics and Prebiotics 7: 1-12.
15. Hardy, H., Harris, J., Lyon, E., Beal, J. and Foey, A.D., 2013. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients 5: 1869-1912.
16. Hugo, A.A., De Antoni, G.L. and Perez, P.F., 2010. Lactobacillus delbrueckii subsp. lactis (strain CIDCA 133) resists the antimicrobial activity triggered by molecules derived from enterocyte-like Caco-2 cells. Letters in Applied Microbiology 50: 335-340.
17. Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., Ishiguro, S., Miyaoka, E., Sobue, T. and Kakizoe, T., 2005. Randomised trial of dietary fibre and Lactobacillus casei administration for prevention of colorectal tumours. International Journal of Cancer 116: 762-767.
18. Kalliomaki, M., Salminen, S., Poussat, T., Arvilommi, H. and Isolauri, E., 2003. Probiotics and prevention of atopic disease: 4year follow-up of a randomised placebo-controlled trial. The Lancet 361: 1869-1871.
19. Kanda, N., Kamata, M., Tada, Y., Ishikawa, T., Sato, S. and Watanabe, S., 2011. Human β-defensin-2 enhances IFNγ and IL-10 production and suppresses IL-17 production in T cells. Journal of Leukocyte Biology 89: 935-944.
20. Kluver, E., Adermann, K. and Schulz, A., 2006. Synthesis and structure-activity relationship of β-defensins, multifunctional peptides of the immune system. Journal of Peptide Science 12: 243-257.
21. -ΔΔCtmethod. Methods 25: 402-408.
22. Moore, K.W., De Waal Malefyt, R., Coffman, R.L. and O'Garra, A., 2001. Interleukin-10 and the interleukin-10 receptor. Annual Reviews in Immunology 19: 683-765.
23. Parry, S., Sebbag, M., Feldmann, M. and Brennan, F.M., 1997. Contact with T cells modulates monocyte IL-10 production: role of T cell membrane TNF-alpha. Journal of Immunology 158: 3673-3681.
24. Presicce, P., Giannelli, S., Taddeo, A., Villa, M.L. and Della Bella, S., 2009. Human defensins activate monocyte-derived dendritic cells, promote the production of proinflammatory cytokines, and up-regulate the surface expression of CD91. Journal of Leukocyte Biology 86: 941-948.
25. Rafter, J., Bennet, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P.C., Klinder, A., O'Riordan, M., O'Sullivan, G.C., Pool-Zobel, B., Rechkemmer, G., Roller, M., Rowland, I., Salvadori, M., Thijs, H., Van Loo, J., Watzl, B. and Collins, J.K., 2007. Dietary synbiotics reduce cancer risk factors in polypectomised and colon cancer patients. American Journal of Clinical Nutrition 85: 488-496.
26. Savvidou, S., 2009. Selection of a chicken Lactobacillus strain with probiotic properties and its application in poultry production. PhD thesis, University of Plymouth, Plymouth, UK.
27. Schlee, M., Harder, J., Koten, B., Stange, E.F., Wehkamp, J. and Fellermann, K., 2008. Probiotic lactobacilli and VSL#3 induce enterocyte β-defensin 2. Clinical and Experimental Immunology 151: 528-535.
28. Schlee, M., Wehkamp, J., Altenhoefer, A., Oelschlaeger, T.A., Stange, E.F. and Fellermann, K., 2007. Induction of human beta-defensin-2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infection and Immunity 75: 2399-2407.
29. Shi, J., Aono, S., Lu, W., Ouellette, A.J., Hu, X., Ji, Y., Wang, L., Lenz, S., Van Ginkel, F.W., Liles, M., Dykstra, C., Morrison, E.E. and Elson, C.O., 2007. A novel role for defensins in intestinal homeostasis: regulation of IL-1β secretion. Journal of Immunology 179: 1245-1253.
30. Strober, W., Zhang, F., Kitani, A., Fuss, I., Fichtner-Feigl, S., 2010. Proinflammatory cytokines underlying the inflammation of Crohn's disease. Current Opinions in Gastroenterology 26: 301-307.
31. Territo, M.M., Ganz, T., Selsted, M.E. and Lehrer, R., 1989. Monocytechemotactic activity of defensins from human neutrophils. Journal of Clinical Investigation 84: 2017-2020.
32. Tilg, H., Van Montfrans, C., Van den Ende, A., Kaser, A., Van Deventer, S.J.H., Schreiber, S., Gregor, M., Ludwiczek, O., Rutgeerts, P., Gasche, C., Koningsberger, J.C., Abreu, L., Kuhn, I., Cohard, M., LeBeaut, A., Grint, P. and Weiss, G., 2002. Treatment of Crohn's disease with recombinant human interleukin 10 induces the proinflammatory cytokine interferon gamma. Gut 50: 191-195.
33. Tudor, C., Marchese, F.P., Hitti, E., Aubareda, A., Rawlinson, L., Gaestel, M., Blackshear, P.J., Clark, A.R., Saklatvala, J. and Dean J.L.E., 2009. The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and proinflammatory mediator mRNAs in murine macrophages. FEBS Letters 583: 1933-1938.
34. Van Wetering, S., Mannesse-Lazeroms, S.P., Dijkman, J.H. and Hiemstra, P.S., 1997a. Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. Journal of Leukocyte Biology 62: 217-226.
35. Van Wetering, S., Mannesse-Lazeroms, S.P.G., Van Sterkenburg, M.A.J.A., Daha, M.R., Dijkman, J.H. and Hiemstra, P.S., 1997b. Effect of defensins on IL-8 synthesis in airway epithelial cells. American Journal of Physiology - Lung Cellular and Molecular Physiology 272: L888-L889.
36. Vora, P., Youdim, A., Thomas, L.S., Fukata, M., Tesfay, S.Y., Lukasek, K., Michelsen, K.S., Wada, A., Hirayama, T., Arditi, M. and Abreau, M., 2004. Beta-defensin-2 expression is regulated by TLR signalling in intestinal epithelial cells. Journal of Immunology 173: 5398-5405.
37. Walker, W.A., 2008. Mechanisms of action of probiotics. Clinical Infectious Diseases 46: S87-S91.
38. Wehkamp, J., Harder, J., Wehkamp, K., Meissner, BV-W., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Bengmark, S., Fellermann, K., Schroder, J.M. and Stange, E.F., 2004. NF-kappaB- and AP-1- mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infection and Immunity 72: 5750-5758.
39. Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K.R., Fellermann, K., Schroeder, J.M. and Stange, E.F., 2003. Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflammatory Bowel Diseases 9: 215-223.
40. Wehkamp, J., Schmid, M., Fellermann, K. and Stange, E.F., 2005. Defensin deficiency, intestinal microbes and the clinical phenotypes of Crohn's disease. Journal of Leukocyte Biology 77: 460-465.
41. Yang, D., Chen, Q., Chertov, O. And Oppenheim, J.J., 2000. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. Journal of Leukocyte Biology 68: 9-14.
42. Young, S.L., Simon, M.A., Baird, M.A., Tannock, G.W., Bibiloni, R., Spencely, K., Lane, J.M., Fitzharris, P., Crane, J., Town, I., Addo- Yobo, E., Murray, C.S. and Woodcock, A., 2004. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clinical and Diagnostic Laboratory Immunology 11: 686-690.